Rhumbline Advisers Biolife Solutions Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Biolife Solutions Inc stock. As of the latest transaction made, Rhumbline Advisers holds 83,018 shares of BLFS stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,018

Previous 87,473 5.09%

Holding current value

$2.18 Million

Previous $1.87 Million 10.83%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$19.19 - $26.52 $85,491 - $118,146	-4,455 Reduced 5.09%	83,018 $2.08 Million
Q2 2024 Aug 01, 2024	BUY	$15.14 - $22.99 $59,227 - $89,936	3,912 Added 4.68%	87,473 $1.87 Million
Q1 2024 May 09, 2024	BUY	$15.35 - $18.82 $15,150 - $18,575	987 Added 1.2%	83,561 $1.55 Million
Q4 2023 Feb 08, 2024	BUY	$8.99 - $16.86 $19,840 - $37,210	2,207 Added 2.75%	82,574 $1.34 Million
Q3 2023 Nov 09, 2023	BUY	$10.81 - $22.96 $1,253 - $2,663	116 Added 0.14%	80,367 $1.11 Million
Q2 2023 Aug 08, 2023	SELL	$17.19 - $24.34 $121,997 - $172,740	-7,097 Reduced 8.12%	80,251 $1.77 Million
Q1 2023 May 11, 2023	BUY	$17.67 - $26.07 $83,349 - $122,972	4,717 Added 5.71%	87,348 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$16.95 - $25.07 $68,461 - $101,257	4,039 Added 5.14%	82,631 $1.5 Million
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $94,867 - $173,016	6,480 Added 8.99%	78,592 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$10.54 - $24.2 $378,533 - $869,118	35,914 Added 99.22%	72,112 $996,000
Q1 2022 May 12, 2022	SELL	$20.81 - $37.29 $330,337 - $591,941	-15,874 Reduced 30.48%	36,198 $823,000
Q4 2021 Feb 10, 2022	SELL	$32.99 - $58.55 $254,748 - $452,123	-7,722 Reduced 12.91%	52,072 $1.94 Million
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $1.55 Million - $2.22 Million	36,767 Added 159.67%	59,794 $2.53 Million
Q2 2021 Aug 05, 2021	BUY	$29.51 - $44.62 $267,213 - $404,034	9,055 Added 64.81%	23,027 $1.03 Million
Q1 2021 May 06, 2021	BUY	$32.95 - $44.24 $11,038 - $14,820	335 Added 2.46%	13,972 $503,000
Q4 2020 Feb 10, 2021	BUY	$27.5 - $45.75 $69,437 - $115,518	2,525 Added 22.72%	13,637 $544,000
Q3 2020 Nov 12, 2020	BUY	$16.04 - $28.94 $178,236 - $321,581	11,112 New	11,112 $322,000

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Biolife Solutions Inc Transaction History